Washington University in St. Louis

Crowdsourced supercomputing project sets sights on coronavirus

Folding@home targets COVID-19, number of volunteer ‘folders’ skyrockets
20-Mar-2020 1:10 PM EDT, by Washington University in St. Louis

Newswise — People around the world are isolating themselves to help slow the spread of COVID-19. But there is another way those confined to their homes — but connected online — can join the fight against the novel coronavirus. Among the research programs racing to develop therapies and vaccines for this new pandemic virus is one of the largest crowdsourced supercomputing projects in the world.

Led by computational biophysicist Greg Bowman, PhD, an associate professor of biochemistry and molecular biophysics at Washington University School of Medicine in St. Louis, the project is called Folding@home. It relies on the collective power of volunteers’ home computers to perform the complex calculations required to simulate protein dynamics.

Volunteers from all over the world can install a software program that runs those calculations when a computer otherwise would sit idle. Often motivated by personal experience with various diseases, the participants get to select an area of contribution, such as boosting cancer research, preventing Alzheimer’s disease or – now – fighting the novel coronavirus.

For example, Bowman and his team are trying to understand the structure of COVID-19’s spike protein, which is what the virus uses to infect cells. Such research could reveal ways to block the protein and, consequently, infection. Since announcing in late February the project’s new focus on coronavirus, the number of Folding@home volunteers has skyrocketed, with some 400,000 new folders joining the effort, Bowman said.

“The response so far has been overwhelming and wonderful, but there is always more useful science to be done,” he said. “Understanding all the various shapes that the spike protein can take on as its molecules bounce and shift can lead to the development of new drugs that can block it, stopping the virus from infecting more cells. We are continuing to scale up our research as fast as we can.”

Bowman has shared what could be thought of as a first glimpse of the moving COVID-19 spike protein. It consists of three different proteins that fit together like a 3D puzzle. The simulation reveals a pocket that helps the virus bind to human cells and infect them.

In the spirit of open science and the rapid sharing of new knowledge about COVID-19, Bowman said the research team will publish findings on free and open-access preprint sites, such as bioRxiv.

To join the effort and put your computer to work against coronavirus, visit https://foldingathome.org.

###

Washington University School of Medicine’s 1,500 faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children’s hospitals. The School of Medicine is a leader in medical research, teaching and patient care, ranking among the top 10 medical schools in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children’s hospitals, the School of Medicine is linked to BJC HealthCare.




Filters close

Showing results

110 of 2816
access_time Embargo lifts in 2 days
Embargo will expire: 6-Aug-2020 11:00 AM EDT Released to reporters: 5-Aug-2020 4:25 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 6-Aug-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise:Video Embedded uab-department-of-pathology-develops-strategy-to-support-guidesafe-entry-testing-process-more-than-200-000-samples
VIDEO
Released: 5-Aug-2020 4:10 PM EDT
UAB Department of Pathology develops strategy to support GuideSafe™ Entry Testing, process more than 200,000 samples
University of Alabama at Birmingham

This strategy will allow for ramping up testing capacity tenfold for the next 20-plus days leading up to the start of school.

Newswise: 239458_web.jpg
Released: 5-Aug-2020 2:50 PM EDT
New findings on enzymes with important role in SARS-CoV-2 infection
Uppsala University

Researchers at Uppsala University have described the presence, throughout the human body, of the enzyme ACE2.

Newswise: Button Project Lets Children See the Faces Behind the Masks
Released: 5-Aug-2020 2:50 PM EDT
Button Project Lets Children See the Faces Behind the Masks
Vanderbilt University Medical Center

When COVID-19 cases began rising in Nashville, masking became a regular part of life across Vanderbilt University Medical Center and Children’s Hospital as one of several public health safety measures to protect employees and patients from potential COVID-19 exposure. Children’s Hospital decided to get creative to ensure that the 1,700 children and families who visit the hospital and clinics each day can see that the same friendly faces they’ve always known still exist behind the masks.

Newswise: 239490_web.jpg
Released: 5-Aug-2020 1:45 PM EDT
Massey scientist suggests COVID-19 should be treated as an acute inflammatory disease
Virginia Commonwealth University (VCU)

The COVID-19 pandemic has had detrimental effects on global infrastructure sectors, including economic, political, health care, education and research systems, and there is still no definitive treatment strategy for the disease.

Newswise: Helping protect medical professionals
Released: 5-Aug-2020 1:05 PM EDT
Helping protect medical professionals
Sandia National Laboratories

A media comprised of a sandwich of materials, tested by Sandia National Laboratories, is being manufactured into N95-like respirators that could be used in local medical facilities. The project originated from the urgent need for personal protective equipment when the COVID-19 outbreak began.

Released: 5-Aug-2020 12:50 PM EDT
UCI scientists get ‘initial hit’ in developing drug to treat COVID-19
University of California, Irvine

Irvine, Calif., Aug. 5, 2020 – When the coronavirus pandemic hit, almost everyone at the University of California, Irvine – and colleges across the nation – had to abandon campus. But James Nowick, professor of chemistry, was not a part of that exodus. That’s because his lab, which designs and constructs chemical molecules, had the right equipment to help in the global push to find treatments for COVID-19.


Showing results

110 of 2816

close
1.37457